JCN List of News Articles

Taipei, Taiwan, January 12, 2026 - (JCN Newswire) - OBI Pharma (4174.TWO) announced that it has entered into a commercial licensing agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharmaceutical company focused on the development of antibodies targeting cancer-related glycans and glycoproteins, for glycan-targeted ADCs. Dr. Heidi Wang, CEO of OBI Pharma, stated: "This strategic partnership leverages the complementary strengths of both organizations. It will not only support the advancement of OBI's ADC product development but also expand opportunities for strategic partnerships utilizing innovative ADC technologies such as GlycOBI. We look forward to closely collaborating with TegMine to further develop this novel ADC, which has the potential to benefit patients with urgent medical needs."

Miami, Florida, USA & Abu Dhabi, United Arab Emirates, January 12, 2026 - (JCN Newswire) - The Argentine Football Association (AFA), which boasts the current FIFA World Cup champions, the Argentina national team, has officially launched the fan experience platform "Vamos Argentina," in partnership with its exclusive agentic AI partner, Verofax. Wassim Merheby, CEO of Verofax, stated: "AFA is pioneering the deployment of an official generative AI experience as a new channel for brand sponsors. By training the AI engine using player data, we can provide a genuine AI experience that incorporates sponsors' brands at a significantly reduced cost compared to traditional methods. AFA has over 100 million official followers and an audience of 250 million to 500 million viewers for matches, with individual players collectively reaching around 900 million followers. Vamos Argentina will achieve unprecedented reach and engagement."

Miami, Florida, January 10, 2026 - (JCN Newswire) - Promiscel, a clinical-stage cell immunotherapy company uniquely positioned in the development of potentially curative cell therapies for cancer patients, announced today that Dr. John Lee, our Chief Medical Officer, will present interim results of our lead asset, PRO CAR - 201A (a CAR T cell therapy targeting STEAP1). This therapy is currently being conducted as the first human Phase 1 clinical trial aimed at treating metastatic castration-resistant prostate cancer (mCRPC). The presentation will take place on January 12, 2025 (Monday) at 11:15 AM Pacific Standard Time at the Franciscan D (Ballroom Level) during the "Biotech Showcase 2026" in San Francisco, California.

Tokyo, January 8, 2026 - (JCN Newswire) - In 2025, the number of malicious files detected by Kaspersky's detection system averaged 500,000 per day, marking a 7% increase compared to the previous year. Certain types of threats have seen a global rise, with detections of password stealers (malware that steals account information) surging by 59% compared to 2024, detections of spyware increasing by 51%, and detections of backdoors rising by 6%. These findings are presented in the Kaspersky Security Bulletin series, which reflects on key cybersecurity trends over the past year. Cyber attacks continue to predominantly target Windows. Throughout 2025, 48% of Windows users were targeted by various types of threats, while this figure was only 29% for Mac users. For the full release, please refer to: https://acnnewswire.com/press-release/japanese/104513/

Tokyo, January 8, 2026 - (JCN Newswire) - CNN International Commercial (CNNIC) and NGK Insulators, Ltd. (President: Shigeru Kobayashi, Headquarters: Nagoya City, hereinafter referred to as "NGK"), a global leader in ceramic technology, will launch a cross-platform campaign to showcase their efforts towards the evolution of cutting-edge technology and the realization of a sustainable future. This campaign will highlight how innovative technologies contribute to solving global challenges and promote digital transformation. NGK will be the exclusive sponsor of CNN's special program "Innovate" (30 minutes), which is scheduled to air on CNN International in January 2026. The program will delve into the behind-the-scenes of business ideas, technological development, and the challenges faced by entrepreneurs, presenting stories that transform the world. Additionally, the campaign will feature digital content showcasing entrepreneurs and business leaders who are paving the way for a sustainable future.

London, January 5, 2026 - (JCN Newswire) - Alpha Growth plc (www.algwplc.com), a leading financial services specialist in the multi-billion dollar longevity-related assets, insurance-linked assets, and wealth management markets, announces that Alpha Longevity Management Ltd, a subsidiary of Alpha Growth plc, has today revealed two significant developments demonstrating the company's ongoing global expansion. RNS Reach: https://www.londonstockexchange.com/news-article/market-news/addition-to-investment-team-and-launch-of-new-fund/17397628 Source: Alpha Growth plc